This Article Full Text Full Text (PDF) All Versions of this Article: 40/3/773    most recent STROKEAHA.108.530832v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zarei, M. Articles by Barkhof, F. Search for Related Content PubMed PubMed Citation Articles by Zarei, M. Articles by Barkhof, F. Pubmed/NCBI databases Medline Plus Health Information Alzheimer's Disease Related Collections CT and MRI Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2009;40:773.)
© 2009 American Heart Association, Inc.

Original Contributions

Regional White Matter Integrity Differentiates Between Vascular Dementia and Alzheimer Disease

Mojtaba Zarei, MRCP; Jeske S. Damoiseaux, PhD; Ciro Morgese, DPhil; Christian F. Beckmann, DPhil; Steve M. Smith, DPhil; Paul M. Matthews, FRCP; Philip Scheltens, MD; Serge A.R.B. Rombouts, PhD Frederik Barkhof, MD

From FMRIB Centre (M.Z., C.M., C.F.B., S.M.S., P.M.M.), University Oxford, Oxford, UK; Departments of Neurology (J.S.D., P.S.) and Radiology (F.B.), VU University Medical Center, Amsterdam, Netherlands; Department of Radiology (S.A.R.B.R.), Leiden University Medical Center, Leiden, Netherlands.

Correspondence to Dr M. Zarei, FMRIB Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK. E-mail mojtaba{at}fmrib.ox.ac.uk

Background and Purpose— Considerable clinical and radiological overlap between vascular dementia (VaD) and Alzheimer disease (AD) often makes the diagnosis difficult. Diffusion-tensor imaging studies showed that fractional anisotropy (FA) could be a useful marker for white matter changes. This study aimed to identify regional FA changes to identify a biomarker that could be used to differentiate VaD from AD.

Methods— T1-weighted and diffusion-tensor imaging scans were obtained in 13 VaD patients, 16 AD patients, and 22 healthy elderly controls. We used tract-based spatial statistics to study regional changes in fractional anisotropy in AD, VaD, and elderly controls. We then used probabilistic tractography to parcel the corpus callosum in 7 regions according to its connectivity with major cerebral cortices using diffusion-tensor imaging data set. We compared the volume and mean FA in each set of transcallosal fibers between groups using ANOVA and then applied a discriminant analysis based on FA and T2-weighted imaging measures.

Results— FA reduction in forceps minor was the most significant area of difference between AD and VaD. Segmentation of the corpus callosum using tractography and comparison of FA changes of each segment confirmed the FA changes in transcallosal prefrontal tracts of patients with VaD when compared to AD. The best discriminant model was the combination of transcallosal prefrontal FA and Fazekas score with 87.5% accuracy, 100% specificity, and 93% sensitivity (P<0.0001).

Conclusion— Integrating mean FA in the forceps minor to the Fazekas score provides a useful quantitative marker for differentiating AD from VaD.

Key Words: Alzheimer disease • dementia • diffusion-weighted imaging • MRI • vascular dementia